USP data suggest that the US supply of acyclovir, which is used to treat herpes zoster, genital herpes and chickenpox, may be vulnerable if the Indian government further tightens exports of the product.
India's restriction, which covers 26 active pharmaceutical ingredients and finished dosage forms (13 products total), was implemented more than a week ago to protect its inventories as the coronavirus
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?